Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Induction and Maintenance in Chinese Patients with Crohn's Disease
NCT02499783Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2015
- Primary completion
- May 2017
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in Crohn's disease, sponsored by AbbVie Inc.. Started Aug 2015; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02499783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499783.